We are live on !
Find out more
EntryPoint Capital Portfolio holdings
AUM
$412M
Turnover
50.4%
1-Year Est. Return
28.52%
This Fund
S&P 500
This Quarter Est. Return
+15.49%
1 Year Est. Return
+28.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$70.8M
(+21%)
Cap. Flow
+$36.5M
Cap. Flow % of AUM
Cap. Flow %
8.87%
Top 10 Holdings %
Top 10 Hldgs %
4.34%
Holding
1,002
New
271
Increased
170
Reduced
168
Closed
234
Avg Time Held
0.4
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Huntington Bancshares
HBAN
|
+$1.67M |
| 2 |
Donaldson
DCI
|
+$1.6M |
| 3 |
FedEx
FDX
|
+$1.6M |
| 4 |
Fidelity National Financial
FNF
|
+$1.53M |
| 5 |
Graco
GGG
|
+$1.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cadence Design Systems
CDNS
|
+$1.48M |
| 2 |
TIC Solutions Inc
TIC
|
+$1.48M |
| 3 |
Schrodinger
SDGR
|
+$1.27M |
| 4 |
Exelon
EXC
|
+$1.23M |
| 5 |
Visteon
VC
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18% |
| 2 | Financials | 16.8% |
| 3 | Healthcare | 15.07% |
| 4 | Technology | 12.86% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Metropolitan Bank Holding Corp
MCB
$1.13B
| $436K | 0.11% |
4,418
| – | – |
2026 Q1
1 quarter
|
|
377
Lineage Inc
LINE
$7.8B
| $432K | 0.1% |
9,980
| – | – |
2026 Q1
1 quarter
|
|
378
Phinia Inc
PHIN
$2.09B
| $431K | 0.1% |
5,231
| – | – |
2026 Q1
1 quarter
|
|
379
General Mills
GIS
$17.4B
| $431K | 0.1% |
12,380
| – | – |
2026 Q1
1 quarter
|
|
380
Cohen & Steers
CNS
$3.61B
| $431K | 0.1% |
5,658
-507
| -8% | -$35.9K |
2025 Q3
3 quarters
|
|
381
Cogent Biosciences
COGT
$5.45B
| $430K | 0.1% |
11,123
| – | – |
2026 Q1
1 quarter
|
|
382
Aspen Aerogels
ASPN
$467M
| $430K | 0.1% |
67,794
-78,879
| -54% | -$387K |
2024 Q3
7 quarters
|
|
383
Vicor
VICR
$9.8B
| $430K | 0.1% |
+1,131
| New | +$309K |
2026 Q2
0 quarters
|
|
384
Crescent Energy
CRGY
$5.7B
| $429K | 0.1% |
43,681
+27,811
| +175% | +$340K |
2025 Q3
3 quarters
|
|
385
Beta Bionics
BBNX
$993M
| $429K | 0.1% |
+27,372
| New | +$326K |
2026 Q2
0 quarters
|
|
386
Kulicke & Soffa
KLIC
$4.26B
| $428K | 0.1% |
3,198
-10
| -0.3% | -$980 |
2025 Q3
3 quarters
|
|
387
Illinois Tool Works
ITW
$78.8B
| $428K | 0.1% |
1,581
| – | – |
2026 Q1
1 quarter
|
|
388
SLM Corp
SLM
$4.29B
| $427K | 0.1% |
16,469
-27,676
| -63% | -$623K |
2026 Q1
1 quarter
|
|
389
EXL Service
EXLS
$6.22B
| $427K | 0.1% |
16,506
| – | – |
2026 Q1
1 quarter
|
|
390
Emerson Electric
EMR
$91B
| $426K | 0.1% |
+2,974
| New | +$419K |
2026 Q2
0 quarters
|
|
391
Dave Inc
DAVE
$4.81B
| $425K | 0.1% |
+1,140
| New | +$296K |
2026 Q2
0 quarters
|
|
392
Alaska Air
ALK
$3.74B
| $421K | 0.1% |
+8,058
| New | +$344K |
2026 Q2
0 quarters
|
|
393
Adtran
ADTN
$545M
| $421K | 0.1% |
30,252
-23,194
| -43% | -$362K |
2025 Q3
3 quarters
|
|
394
Invesco
IVZ
$12.9B
| $420K | 0.1% |
+15,923
| New | +$422K |
2026 Q2
0 quarters
|
|
395
Teradyne
TER
$54B
| $419K | 0.1% |
867
-843
| -49% | -$318K |
2025 Q4
2 quarters
|
|
396
Great Southern Bancorp
GSBC
$851M
| $418K | 0.1% |
5,337
-726
| -12% | -$51.2K |
2025 Q3
3 quarters
|
|
397
Agilent Technologies
A
$50.1B
| $418K | 0.1% |
3,150
-1,169
| -27% | -$142K |
2026 Q1
1 quarter
|
|
398
Insulet
PODD
$9.8B
| $418K | 0.1% |
+2,748
| New | +$458K |
2026 Q2
0 quarters
|
|
399
ArcBest
ARCB
$2.92B
| $417K | 0.1% |
+2,905
| New | +$378K |
2026 Q2
0 quarters
|
|
400
Dianthus Therapeutics
DNTH
$4.37B
| $413K | 0.1% |
+4,232
| New | +$370K |
2026 Q2
0 quarters
|
|
Similar funds
EntryPoint Capital's Q2 2026 Portfolio in Review
As of Q2 2026, EntryPoint Capital held 1,002 positions worth $412M, up 21% from $341M the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
EntryPoint Capital deployed $36.5M of net new capital in Q2 2026, opening 271 new positions and adding to 170 existing holdings. Its largest new stake was Huntington Bancshares: 101,010 shares worth $1.79M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Cadence Design Systems, an estimated $1.48M trimmed.
- EntryPoint Capital's largest Q2 2026 buy was Huntington Bancshares: 101,010 shares worth $1.79M.
- EntryPoint Capital added most to Gilead Sciences in Q2 2026, an estimated $1.51M increase.
- EntryPoint Capital's biggest Q2 2026 reduction was Cadence Design Systems, cutting an estimated $1.48M.
- EntryPoint Capital fully exited Exelon in Q2 2026, selling an estimated $1.23M.
- EntryPoint Capital's ten largest holdings make up 4.3% of its $412M portfolio in Q2 2026.
- EntryPoint Capital opened 271 new positions and closed 234 in Q2 2026.
- EntryPoint Capital's portfolio value rose 21% quarter-over-quarter to $412M.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.